{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T15:40:09Z","timestamp":1754062809641,"version":"3.41.2"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"vor","delay-in-days":112,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment and Research Communications"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/j.ctarc.2025.100932","type":"journal-article","created":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T07:32:51Z","timestamp":1746084771000},"page":"100932","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Immunohistological localization of MDM2, MCM2, Fascin, PCNA, EGFR in paraffin section; in the normal and cancerous human ovary"],"prefix":"10.1016","volume":"43","author":[{"given":"Mojgan","family":"Karimi-Zarchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Ali","family":"Khalili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fariba","family":"Binesh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatemeh","family":"Pourhosseini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali Reza","family":"Talebi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azam","family":"Hassanpour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahboubeh","family":"Vatanparast","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctarc.2025.100932_bib0001","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.cryobiol.2018.01.002","article-title":"Evaluation of sheep ovarian tissue cryopreservation with slow freezing or vitrification after chick embryo chorioallantoic membrane transplantation","volume":"81","author":"Vatanparast","year":"2018","journal-title":"Cryobiology"},{"issue":"3","key":"10.1016\/j.ctarc.2025.100932_bib0002","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s00404-018-4838-x","article-title":"GDF9-\u03b2 promotes folliculogenesis in sheep ovarian transplantation onto the chick embryo chorioallantoic membrane (CAM) in cryopreservation programs","volume":"298","author":"Vatanparast","year":"2018","journal-title":"Arch. Gynecol. Obstet."},{"key":"10.1016\/j.ctarc.2025.100932_bib0003","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.fertnstert.2005.09.038","article-title":"Morphological and ultrastructural evaluation of cultured frozen\u2013thawed human fetal ovarian tissue","volume":"85","author":"Sadeu","year":"2006","journal-title":"Fertil. Steril."},{"issue":"1","key":"10.1016\/j.ctarc.2025.100932_bib0004","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ygyno.2004.12.053","article-title":"p53 and mdm2 as prognostic indicators in patients with epithelial ovarian cancer: a multivariate analysis","volume":"97","author":"Dogan","year":"2005","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ctarc.2025.100932_bib0005","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/(SICI)1096-9896(199702)181:2<158::AID-PATH742>3.0.CO;2-8","article-title":"TP53 protein accumulation and gene mutation in relation to overexpression of MDM2 protein in ovarian borderline tumours and stage I carcinomas","volume":"181","author":"Skomedal","year":"1997","journal-title":"J. Pathol.: J. Patholog. Soc. Great Brit. Irel."},{"issue":"6","key":"10.1016\/j.ctarc.2025.100932_bib0006","first-page":"1133","article-title":"Expression of heparanase, Mdm2, and erbB2 in ovarian cancer","volume":"18","author":"Ginath","year":"2001","journal-title":"Int. J. Oncol."},{"issue":"8","key":"10.1016\/j.ctarc.2025.100932_bib0007","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1038\/sj.bjc.6603992","article-title":"Minichromosome maintenance proteins 2 and 5 in non-benign epithelial ovarian tumours: relationship with cell cycle regulators and prognostic implications","volume":"97","author":"Gakiopoulou","year":"2007","journal-title":"Br. J. Cancer"},{"issue":"11","key":"10.1016\/j.ctarc.2025.100932_bib0008","doi-asserted-by":"crossref","first-page":"4418","DOI":"10.1210\/jc.2007-0729","article-title":"Abnormal preantral folliculogenesis in polycystic ovaries is associated with increased granulosa cell division","volume":"92","author":"Stubbs","year":"2007","journal-title":"J. Clin. Endocrinol. Metabol."},{"issue":"8","key":"10.1016\/j.ctarc.2025.100932_bib0009","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1038\/sj.bjc.6601660","article-title":"A novel immunohistochemical method for estimating cell cycle phase distribution in ovarian serous neoplasms: implications for the histopathological assessment of paraffin-embedded specimens","volume":"90","author":"Scott","year":"2004","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.ctarc.2025.100932_bib0010","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1023\/A:1026596609969","article-title":"Increased expression of fascin, motility associated protein, in cell cultures derived from ovarian cancer and in borderline and carcinomatous ovarian tumors","volume":"18","author":"Hu","year":"2000","journal-title":"Clin. Exp. Metastasis"},{"issue":"3B","key":"10.1016\/j.ctarc.2025.100932_bib0011","first-page":"1905","article-title":"Prognostic significance of fascin expression in advanced poorly differentiated serous ovarian cancer","volume":"28","author":"Daponte","year":"2008","journal-title":"Anticancer Res."},{"key":"10.1016\/j.ctarc.2025.100932_bib0012","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0959-8049(01)00231-3","article-title":"EGFR and cancer prognosis","volume":"37","author":"Nicholson","year":"2001","journal-title":"Eur J Cancer"},{"issue":"2","key":"10.1016\/j.ctarc.2025.100932_bib0013","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.bbcan.2008.01.001","article-title":"Clinical implications of the ErbB\/epidermal growth factor (EGF) receptor family and its ligands in ovarian cancer","volume":"1785","author":"Lafky","year":"2008","journal-title":"Biochimica et Biophysica Acta (BBA)-Rev. Cancer"},{"issue":"2","key":"10.1016\/j.ctarc.2025.100932_bib0014","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/bjc.1995.72","article-title":"Proliferating cell nuclear antigen (PCNA) immunostaining-a prognostic factor in ovarian cancer?","volume":"71","author":"Thomas","year":"1995","journal-title":"Br. J. Cancer"},{"issue":"3","key":"10.1016\/j.ctarc.2025.100932_bib0015","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1046\/j.1365-2559.1996.d01-420.x","article-title":"Massive ovarian oedema","volume":"28","author":"Nogales","year":"1996","journal-title":"Histopathology"},{"issue":"3","key":"10.1016\/j.ctarc.2025.100932_bib0016","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1095\/biolreprod54.3.734","article-title":"Immunohistochemical analysis of the microanatomy of primate ovary","volume":"54","author":"Khan-Dawood","year":"1996","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.ctarc.2025.100932_bib0017","article-title":"Fascin in ovarian epithelial tumors","author":"Kostopoulou","year":"2008","journal-title":"Histol. Histopathol."},{"issue":"2","key":"10.1016\/j.ctarc.2025.100932_bib0018","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0002-9378(11)80044-X","article-title":"Epidermal growth factor receptor expression in normal ovarian epithelium and ovarian cancer: I. Correlation of receptor expression with prognostic factors in patients with ovarian cancer","volume":"164","author":"Berchuck","year":"1991","journal-title":"Am. J. Obstetr. Gynecol."},{"key":"10.1016\/j.ctarc.2025.100932_bib0019","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1155\/2008\/284382","article-title":"Association of cortactin, fascin-1 and epidermal growth factor receptor (EGFR) expression in ovarian carcinomas: correlation with clinicopathological parameters","volume":"25","author":"Lin","year":"2008","journal-title":"Dis. Mark."},{"issue":"1","key":"10.1016\/j.ctarc.2025.100932_bib0020","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2174\/1568009053332636","article-title":"MDM2 and human malignancies: expression, clinical pathology, prognostic markers, and implications for chemotherapy","volume":"5","author":"Rayburn","year":"2005","journal-title":"Curr. Cancer Drug Target."},{"issue":"4","key":"10.1016\/j.ctarc.2025.100932_bib0021","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1002\/(SICI)1097-0215(19970822)74:4<438::AID-IJC13>3.0.CO;2-5","article-title":"mdm2 mRNA expression is associated with survival in ovarian cancer","volume":"74","author":"Tanner","year":"1997","journal-title":"Int. J. Cancer"},{"issue":"46","key":"10.1016\/j.ctarc.2025.100932_bib0022","doi-asserted-by":"crossref","first-page":"75328","DOI":"10.18632\/oncotarget.12175","article-title":"MDM2 is a potential therapeutic target and prognostic factor for ovarian clear cell carcinomas with wild type TP53","volume":"7","author":"Makii","year":"2016","journal-title":"Oncotarget"},{"issue":"8","key":"10.1016\/j.ctarc.2025.100932_bib0023","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1038\/bjc.2017.265","article-title":"MDM2 promotes epithelial\u2013mesenchymal transition and metastasis of ovarian cancer SKOV3 cells","volume":"117","author":"Chen","year":"2017","journal-title":"Br. J. Cancer"},{"issue":"4","key":"10.1016\/j.ctarc.2025.100932_bib0024","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1095\/biolreprod.113.115089","article-title":"Epidermal growth factor (EGF) sustains in vitro primordial follicle viability by enhancing stromal cell proliferation via MAPK and PI3K pathways in the prepubertal, but not adult, cat ovary","volume":"90","author":"Fujihara","year":"2014","journal-title":"Biol. Reprod."},{"issue":"6","key":"10.1016\/j.ctarc.2025.100932_bib0025","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/(SICI)1097-0215(19980610)76:6<891::AID-IJC20>3.0.CO;2-4","article-title":"Increased level of p21 in human ovarian tumors is associated with increased expression of CDK2, cyclin A and PNCA","volume":"76","author":"Barboule","year":"1998","journal-title":"Int. J. Cancer"},{"issue":"2\u20133","key":"10.1016\/j.ctarc.2025.100932_bib0026","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0940-2993(96)80039-X","article-title":"Proliferation markers","volume":"48","author":"Iatropoulos","year":"1996","journal-title":"Exper. Toxicol. Pathol."},{"issue":"5","key":"10.1016\/j.ctarc.2025.100932_bib0027","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1073\/pnas.88.5.1958","article-title":"Growth suppression induced by wild-type p53 protein is accompanied by selective down-regulation of proliferating-cell nuclear antigen expression","volume":"88","author":"Mercer","year":"1991","journal-title":"Proceed. Natl. Acad. Sci."}],"container-title":["Cancer Treatment and Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294225000681?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294225000681?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T15:10:41Z","timestamp":1754061041000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468294225000681"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":27,"alternative-id":["S2468294225000681"],"URL":"https:\/\/doi.org\/10.1016\/j.ctarc.2025.100932","relation":{},"ISSN":["2468-2942"],"issn-type":[{"type":"print","value":"2468-2942"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunohistological localization of MDM2, MCM2, Fascin, PCNA, EGFR in paraffin section; in the normal and cancerous human ovary","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment and Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctarc.2025.100932","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100932"}}